Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 4 | 2020 | 638 | 0.880 |
Why?
|
| Prostatic Neoplasms | 6 | 2020 | 794 | 0.780 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 484 | 0.730 |
Why?
|
| Interleukin-10 | 1 | 2020 | 69 | 0.720 |
Why?
|
| Alleles | 4 | 2020 | 284 | 0.540 |
Why?
|
| Smoking | 1 | 2020 | 903 | 0.450 |
Why?
|
| Neoplasms | 1 | 2022 | 1033 | 0.440 |
Why?
|
| HLA-DQ Antigens | 1 | 2008 | 6 | 0.340 |
Why?
|
| Trachoma | 1 | 2008 | 2 | 0.340 |
Why?
|
| HLA-B Antigens | 1 | 2008 | 11 | 0.340 |
Why?
|
| HLA-DR Antigens | 1 | 2008 | 20 | 0.340 |
Why?
|
| Endemic Diseases | 1 | 2008 | 22 | 0.330 |
Why?
|
| Genotype | 5 | 2020 | 641 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 528 | 0.300 |
Why?
|
| Case-Control Studies | 6 | 2021 | 1056 | 0.300 |
Why?
|
| Trypanocidal Agents | 2 | 2016 | 39 | 0.240 |
Why?
|
| Haplotypes | 3 | 2020 | 152 | 0.230 |
Why?
|
| Trypanosoma cruzi | 2 | 2016 | 144 | 0.220 |
Why?
|
| Insect Control | 1 | 2021 | 3 | 0.210 |
Why?
|
| Pest Control, Biological | 1 | 2021 | 6 | 0.210 |
Why?
|
| Hydrocortisone | 1 | 2022 | 72 | 0.210 |
Why?
|
| Triticum | 1 | 2021 | 19 | 0.210 |
Why?
|
| Humans | 14 | 2022 | 34853 | 0.180 |
Why?
|
| Middle Aged | 9 | 2021 | 9642 | 0.180 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 169 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 92 | 0.180 |
Why?
|
| DNA Methylation | 1 | 2022 | 301 | 0.180 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 16 | 0.160 |
Why?
|
| Bacteria | 1 | 2021 | 245 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 26 | 0.160 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 159 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 2 | 2015 | 95 | 0.150 |
Why?
|
| Vitis | 1 | 2017 | 29 | 0.150 |
Why?
|
| BRCA2 Protein | 1 | 2017 | 37 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 47 | 0.150 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 86 | 0.150 |
Why?
|
| Risk Assessment | 1 | 2020 | 727 | 0.150 |
Why?
|
| Aged | 5 | 2020 | 6448 | 0.140 |
Why?
|
| Tubulin | 1 | 2016 | 80 | 0.140 |
Why?
|
| Male | 9 | 2022 | 18870 | 0.130 |
Why?
|
| Chagas Disease | 1 | 2016 | 96 | 0.130 |
Why?
|
| Prostatic Hyperplasia | 1 | 2015 | 33 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2017 | 250 | 0.130 |
Why?
|
| Receptors, Calcitriol | 1 | 2015 | 59 | 0.120 |
Why?
|
| Risk Factors | 2 | 2020 | 3414 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 287 | 0.110 |
Why?
|
| Genes, MHC Class I | 1 | 2013 | 13 | 0.110 |
Why?
|
| Genes, MHC Class II | 1 | 2013 | 20 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 781 | 0.110 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 43 | 0.110 |
Why?
|
| Mutation | 1 | 2017 | 1023 | 0.110 |
Why?
|
| Cytotoxins | 1 | 2012 | 10 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2012 | 118 | 0.110 |
Why?
|
| Naphthoquinones | 1 | 2012 | 35 | 0.100 |
Why?
|
| Adult | 5 | 2022 | 11034 | 0.090 |
Why?
|
| Histocompatibility Testing | 1 | 2008 | 7 | 0.090 |
Why?
|
| Tanzania | 1 | 2008 | 7 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 67 | 0.080 |
Why?
|
| Porins | 1 | 2008 | 18 | 0.080 |
Why?
|
| Mouth Mucosa | 1 | 2008 | 33 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2008 | 155 | 0.080 |
Why?
|
| Female | 6 | 2022 | 19873 | 0.080 |
Why?
|
| Chlamydia trachomatis | 1 | 2008 | 66 | 0.080 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 184 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2008 | 392 | 0.080 |
Why?
|
| Rural Population | 1 | 2008 | 253 | 0.070 |
Why?
|
| Young Adult | 3 | 2022 | 4012 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1426 | 0.070 |
Why?
|
| Adolescent | 2 | 2022 | 5035 | 0.070 |
Why?
|
| Risk | 2 | 2015 | 256 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 58 | 0.050 |
Why?
|
| Saliva | 1 | 2022 | 97 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 232 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2022 | 213 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 859 | 0.050 |
Why?
|
| DNA | 1 | 2022 | 549 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 650 | 0.040 |
Why?
|
| Recurrence | 1 | 2017 | 125 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2017 | 131 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 89 | 0.040 |
Why?
|
| Age of Onset | 1 | 2017 | 98 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 269 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 149 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 5668 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 249 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 239 | 0.030 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2015 | 5 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 707 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 154 | 0.030 |
Why?
|
| United States | 2 | 2017 | 3894 | 0.030 |
Why?
|
| Child | 1 | 2022 | 2875 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 1124 | 0.030 |
Why?
|
| Africa, Western | 1 | 2012 | 7 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 58 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1425 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 60 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2333 | 0.030 |
Why?
|
| Animals | 2 | 2021 | 14307 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 271 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 649 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2013 | 1352 | 0.020 |
Why?
|